Cannabis Watch: Cannabis stocks rocked as FDA warning undermines case for CBD investments

This post was originally published on this site

Cannabis stocks were slammed anew on Tuesday, after the U.S. Food and Drug Administration issued new guidance on CBD that included a stark warning that it can cause liver injury and other damage to the human body.

Add Comment